Study governance

Management Committee

The 45 and Up Study Management Committee brings together representatives from the Community and Ethical Oversight Committee, the Scientific Advisory Committee and the Partners Committee, to advise the Sax Institute management and Board on the appropriate conduct of the Study. This committee meets four times each year

Current membership

Professor Sally Redman (Chair)
Chief Executive Officer
The Sax Institute

Professor Bruce Armstrong
(Chair Scientific Advisory Committee)
Head, School of Public Health
The University of Sydney

Professor Mark Harris
(Representative Scientific Advisory Committee)
Executive Director, Centre for Primary Health Care and Equity
The University of New South Wales

Ms Marianne Karam
Chief Operating Officer
The Sax Institute

Dr Andrew Penman
(Representative Partners’ Committee)
Chief Executive Officer
The Cancer Council of New South Wales

Ms Philippa Smith
(Chair Community and Ethical Oversight Committee)
Former Chief Executive Officer
Association of Superannuation Funds of Australia

Ms Sarah Thackway
(Representative NSW Health)
Director, Epidemiology and Research
NSW Health

Terms of reference

There terms of reference for the Management Committee are to: 

  • monitor the progress of the Study against key performance measures and milestones
  • oversee the development and implementation of a risk management plan for the Study
  • provide advice to the Board and CEO of the Sax Institute about issues key to the long term success of the Study. These will include but are not be limited to strategies to ensure:

- Scientific rigour
- Adequate funding and infrastructure
- Effective management of partnerships
- High quality research governance
- Appropriate use of the data